Edward Tenthoff
Stock Analyst at Piper Sandler
(4.42)
# 1,246
Out of 5,128 analysts
1291
Total ratings
36.8%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by Edward Tenthoff
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRNA Moderna | Reiterated: Buy | $305 | $231.35 | +31.83% | 115 | Nov 13, 2026 | |
| ACRV Acrivon Therapeutics | Reiterated: Buy | $8 | $1.46 | +447.95% | 7 | Nov 11, 2026 | |
| BMEA Biomea Fusion | Reiterated: Buy | $4 | $0.5627 | +610.86% | 9 | Nov 11, 2026 | |
| CAPR Capricor Therapeutics | Reiterated: Buy | $25 | $10.24 | +144.14% | 18 | Nov 11, 2026 | |
| INO Inovio Pharmaceuticals | Reiterated: Buy | $4 → $6 | $1.46 | +310.96% | 12 | Nov 11, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $126 | $47.15 | +167.23% | 77 | Nov 10, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $410 | $156.65 | +161.73% | 104 | Nov 10, 2026 | |
| GLUE Monte Rosa Therapeutics | Reiterated: Buy | $37 | $9.31 | +297.42% | 21 | Nov 10, 2026 | |
| CRSP CRISPR Therapeutics AG | Reiterated: Buy | $110 | $42.62 | +158.09% | 69 | Nov 9, 2026 | |
| CAMP Camp4 Therapeutics | Reiterated: Buy | $15 | $4.09 | +266.75% | 16 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $2.04 | +488.24% | 12 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.34 | +497.01% | 40 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $64 | $18.54 | +245.20% | 24 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.67 | +139.52% | 32 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $6.87 | +191.12% | 35 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $12.57 | +106.84% | 5 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $16 | $6.07 | +163.59% | 9 | Oct 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.63 | +145.40% | 22 | Oct 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $17.01 | +176.31% | 26 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 → $39 | $13.10 | +197.71% | 16 | Aug 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.7276 | +724.63% | 7 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $38.13 | -13.45% | 47 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $6.23 | +140.77% | 25 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $23 → $3 | $3.68 | -18.48% | 20 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $7 | $0.6552 | +968.38% | 19 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $104 → $48 | $1.08 | +4,344.44% | 16 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $1.41 | +1,318.44% | 14 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $98 → $125 | $127.17 | -1.71% | 21 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $9.59 | +108.55% | 28 | Dec 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $2 | $17.50 | n/a | 13 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $0.383 | n/a | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $3.17 | n/a | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $0.0001 | n/a | 20 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $3.45 | n/a | 14 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $0.5 | $12.48 | n/a | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $13 | $6.21 | n/a | 10 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 → $0.3 | $0.000001 | n/a | 6 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1 → $38 | $102.91 | n/a | 8 | Oct 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 → $44 | $16.40 | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $13 | $0.6601 | n/a | 14 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $60 | $12.89 | n/a | 15 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $323 | $542.62 | n/a | 49 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $9 | $1.10 | n/a | 9 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $40 | $56.16 | n/a | 17 | Aug 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $36 | $69.84 | n/a | 34 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $309 → $250 | $981.33 | n/a | 21 | Jun 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $1.5 | $0.9184 | n/a | 2 | Jun 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $5 → $2.5 | $0.90 | n/a | 5 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $70 → $90 | $167.95 | n/a | 3 | Mar 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.000001 | n/a | 4 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $5 → $60 | $2.70 | n/a | 6 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 → $208 | $16.01 | n/a | 44 | Jun 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $15.67 | n/a | 1 | Jun 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $90 → $5 | $8.76 | n/a | 23 | Feb 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.000001 | n/a | 1 | Dec 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $19 | $57.42 | n/a | 5 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $4 → $0.1 | $0.0001 | n/a | 8 | Mar 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $5 | $0.000001 | n/a | 9 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $557 | $951.19 | n/a | 35 | Sep 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $0.1379 | n/a | 6 | Feb 9, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $4.72 | n/a | 5 | Sep 7, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $86.55 | n/a | 1 | Aug 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1 | $0.000001 | n/a | 1 | Jul 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $20 | $27.31 | n/a | 1 | Jul 23, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $0.372 | n/a | 1 | Mar 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.5718 | n/a | 1 | Feb 20, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $2.5 | $8.03 | n/a | 1 | Dec 31, 2012 |
Moderna
Nov 13, 2026
Reiterated: Buy
Price Target: $305
Current: $231.35
Upside: +31.83%
Acrivon Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $8
Current: $1.46
Upside: +447.95%
Biomea Fusion
Nov 11, 2026
Reiterated: Buy
Price Target: $4
Current: $0.5627
Upside: +610.86%
Capricor Therapeutics
Nov 11, 2026
Reiterated: Buy
Price Target: $25
Current: $10.24
Upside: +144.14%
Inovio Pharmaceuticals
Nov 11, 2026
Reiterated: Buy
Price Target: $4 → $6
Current: $1.46
Upside: +310.96%
Arrowhead Pharmaceuticals
Nov 10, 2026
Reiterated: Buy
Price Target: $126
Current: $47.15
Upside: +167.23%
Alnylam Pharmaceuticals
Nov 10, 2026
Reiterated: Buy
Price Target: $410
Current: $156.65
Upside: +161.73%
Monte Rosa Therapeutics
Nov 10, 2026
Reiterated: Buy
Price Target: $37
Current: $9.31
Upside: +297.42%
CRISPR Therapeutics AG
Nov 9, 2026
Reiterated: Buy
Price Target: $110
Current: $42.62
Upside: +158.09%
Camp4 Therapeutics
Nov 6, 2026
Reiterated: Buy
Price Target: $15
Current: $4.09
Upside: +266.75%
Nov 6, 2026
Reiterated: Buy
Price Target: $12
Current: $2.04
Upside: +488.24%
Nov 6, 2026
Reiterated: Buy
Price Target: $8
Current: $1.34
Upside: +497.01%
Nov 5, 2026
Reiterated: Buy
Price Target: $64
Current: $18.54
Upside: +245.20%
Nov 5, 2026
Reiterated: Buy
Price Target: $4
Current: $1.67
Upside: +139.52%
Nov 4, 2026
Reiterated: Buy
Price Target: $20
Current: $6.87
Upside: +191.12%
Oct 14, 2026
Reiterated: Buy
Price Target: $26
Current: $12.57
Upside: +106.84%
Oct 14, 2026
Reiterated: Buy
Price Target: $12 → $16
Current: $6.07
Upside: +163.59%
Oct 6, 2026
Reiterated: Buy
Price Target: $4
Current: $1.63
Upside: +145.40%
Sep 29, 2026
Reiterated: Buy
Price Target: $47
Current: $17.01
Upside: +176.31%
Aug 27, 2026
Reiterated: Buy
Price Target: $35 → $39
Current: $13.10
Upside: +197.71%
Aug 12, 2026
Reiterated: Buy
Price Target: $6
Current: $0.7276
Upside: +724.63%
Aug 6, 2026
Reiterated: Buy
Price Target: $33
Current: $38.13
Upside: -13.45%
Jun 10, 2026
Reiterated: Buy
Price Target: $15
Current: $6.23
Upside: +140.77%
Jun 2, 2026
Downgraded: Sell
Price Target: $23 → $3
Current: $3.68
Upside: -18.48%
May 14, 2026
Reiterated: Buy
Price Target: $4 → $7
Current: $0.6552
Upside: +968.38%
May 12, 2026
Rated: Buy
Price Target: $104 → $48
Current: $1.08
Upside: +4,344.44%
Feb 13, 2026
Reiterated: Hold
Price Target: $20
Current: $1.41
Upside: +1,318.44%
Dec 9, 2025
Reiterated: Buy
Price Target: $98 → $125
Current: $127.17
Upside: -1.71%
Dec 4, 2025
Reiterated: Buy
Price Target: $20
Current: $9.59
Upside: +108.55%
Apr 1, 2025
Reiterated: Buy
Price Target: $3 → $2
Current: $17.50
Upside: n/a
Mar 28, 2025
Reiterated: Buy
Price Target: $65
Current: $0.383
Upside: n/a
Feb 7, 2025
Reiterated: Buy
Price Target: $60
Current: $3.17
Upside: n/a
Oct 23, 2024
Reiterated: Buy
Price Target: $5
Current: $0.0001
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $52
Current: $3.45
Upside: n/a
Aug 17, 2023
Reiterated: Hold
Price Target: $0.5
Current: $12.48
Upside: n/a
Apr 11, 2023
Reiterated: Buy
Price Target: $9 → $13
Current: $6.21
Upside: n/a
Feb 23, 2023
Downgraded: Hold
Price Target: $3 → $0.3
Current: $0.000001
Upside: n/a
Oct 27, 2022
Upgraded: Buy
Price Target: $1 → $38
Current: $102.91
Upside: n/a
Aug 25, 2022
Reiterated: Buy
Price Target: $37 → $44
Current: $16.40
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $20 → $13
Current: $0.6601
Upside: n/a
May 23, 2022
Reiterated: Buy
Price Target: $160 → $60
Current: $12.89
Upside: n/a
Oct 18, 2021
Reiterated: Buy
Price Target: $323
Current: $542.62
Upside: n/a
Sep 20, 2021
Reiterated: Buy
Price Target: $7 → $9
Current: $1.10
Upside: n/a
Aug 8, 2021
Reiterated: Buy
Price Target: $42 → $40
Current: $56.16
Upside: n/a
Jun 28, 2021
Reiterated: Buy
Price Target: $36
Current: $69.84
Upside: n/a
Jun 7, 2021
Reiterated: Hold
Price Target: $309 → $250
Current: $981.33
Upside: n/a
Jun 30, 2020
Reiterated: Buy
Price Target: $3 → $1.5
Current: $0.9184
Upside: n/a
May 12, 2020
Downgraded: Hold
Price Target: $5 → $2.5
Current: $0.90
Upside: n/a
Mar 20, 2020
Upgraded: Buy
Price Target: $70 → $90
Current: $167.95
Upside: n/a
Dec 11, 2019
Reiterated: Buy
Price Target: $10
Current: $0.000001
Upside: n/a
Sep 5, 2019
Rated: Hold
Price Target: $5 → $60
Current: $2.70
Upside: n/a
Jun 21, 2019
Reiterated: Buy
Price Target: $200 → $208
Current: $16.01
Upside: n/a
Jun 4, 2019
Reiterated: Buy
Price Target: $32
Current: $15.67
Upside: n/a
Feb 28, 2019
Downgraded: Sell
Price Target: $90 → $5
Current: $8.76
Upside: n/a
Dec 12, 2018
Reiterated: Buy
Price Target: $30
Current: $0.000001
Upside: n/a
Nov 6, 2018
Reiterated: Buy
Price Target: $16 → $19
Current: $57.42
Upside: n/a
Mar 12, 2018
Downgraded: Sell
Price Target: $4 → $0.1
Current: $0.0001
Upside: n/a
Nov 2, 2017
Reiterated: Buy
Price Target: $17 → $5
Current: $0.000001
Upside: n/a
Sep 11, 2017
Reiterated: Buy
Price Target: $557
Current: $951.19
Upside: n/a
Feb 9, 2017
Reiterated: Buy
Price Target: $5 → $4
Current: $0.1379
Upside: n/a
Sep 7, 2016
Reiterated: Buy
Price Target: $1
Current: $4.72
Upside: n/a
Aug 18, 2016
Reiterated: Buy
Price Target: $35
Current: $86.55
Upside: n/a
Jul 9, 2015
Downgraded: Hold
Price Target: $1
Current: $0.000001
Upside: n/a
Jul 23, 2013
Downgraded: Sell
Price Target: $20
Current: $27.31
Upside: n/a
Mar 4, 2013
Rated: Buy
Price Target: $6
Current: $0.372
Upside: n/a
Feb 20, 2013
Reiterated: Buy
Price Target: $6
Current: $0.5718
Upside: n/a
Dec 31, 2012
Rated: Buy
Price Target: $2.5
Current: $8.03
Upside: n/a